| Literature DB >> 23372508 |
Abstract
Is 'coverage with evidence development' a happy medium between 'no evidence, no coverage,' and the sky-high promise of some new biologic therapies, diagnostics, and devices? Medicare plans to find out. The application of CED raises a number of questions, the answers to which may determine whether it is a suitable model for private payers trying to answer the value equation.Entities:
Year: 2007 PMID: 23372508 PMCID: PMC3555183
Source DB: PubMed Journal: Biotechnol Healthc ISSN: 1554-169X